EPS Corporation Partners with ArisGlobal for Enhanced Safety Management
EPS Corporation, a prominent contract research organization in Japan, is set to innovate its pharmacovigilance operations by selecting ArisGlobal's LifeSphere MultiVigilance system. This strategic move aims to bolster compliance, enhance efficiency, and streamline safety case processing while meeting the evolving needs of its sponsor partners.
Enhancing Operational Efficiency and Compliance
By adopting LifeSphere MultiVigilance, EPS Corporation will revolutionize its case processing systems. This modernization will promote operational consistency and ensure alignment with both PMDA and global regulatory requirements. With increasing case volumes, EPS recognizes the necessity for a scalable solution that can support its multilingual sponsor base.
The Importance of Modern Safety Technology
The investment in modern safety technology is a critical step in delivering what matters most to EPS's sponsors: accuracy, speed, and compliance. LifeSphere MultiVigilance is designed to reinforce EPS’s operational framework, enhancing data quality and establishing a solid groundwork for future advancements in automation and collaboration.
Broader Implications for CROs
EPS’s decision reflects a growing trend among contract research organizations, both in Japan and globally, to adopt modern, automation-capable pharmacovigilance systems. By centralizing case processing through LifeSphere MultiVigilance, EPS will not only lessen manual tasks but also improve consistency in global reporting. This shift is vital in serving sponsors who contend with increasingly complex safety requirements.
Industry Leader Insight
Zhiyi Chen, Senior Vice President of ArisGlobal for the APAC region, noted, "EPS is demonstrating how CROs can scale effectively by modernizing core safety operations. We're proud to support their transformation and look forward to driving continued innovation together." This collaboration not only emphasizes a commitment to high-quality pharmacovigilance but also to building a next-generation safety infrastructure.
About EPS Corporation
EPS Corporation stands as Japan's largest contract research organization, offering a wide array of services that support pharmaceutical and biotechnology companies in both domestic and international markets. Their commitment to healthcare innovation is driven by excellence, efficiency, and strong partnerships.
About ArisGlobal
ArisGlobal is an AI-first technology enterprise that is reshaping how leading life sciences companies develop new products and deliver significant breakthroughs to the market. With its headquarters based in the United States, ArisGlobal also maintains regional offices across Europe, India, Japan, and China. To stay updated with the latest developments, following ArisGlobal on LinkedIn is encouraged.
Frequently Asked Questions
What is LifeSphere MultiVigilance?
LifeSphere MultiVigilance is a safety case processing system developed by ArisGlobal, designed to enhance operational efficiency in pharmacovigilance.
Why did EPS Corporation choose ArisGlobal?
EPS Corporation selected ArisGlobal to modernize its pharmacovigilance case processing system, aiming for better compliance and operational efficiency.
What benefits does MultiVigilance provide to EPS Corporation?
MultiVigilance provides scalability, improved data quality, and a foundation for future automation in safety case processing.
How does this partnership benefit sponsors?
This partnership enhances the accuracy, speed, and compliance of pharmacovigilance services for EPS's sponsors.
Where are ArisGlobal's offices located?
ArisGlobal has offices in the United States, Europe, India, Japan, and China, providing global support for its technologies.
